2026 Brooklyn Lung Cancer Conference

Accreditation: 8.50 ACPE Pharmacy | 8.50 ABIM MOC II | 8.50 Nursing Contact Hours | 8.50 AMA PRA Category 1 Credit™

Venue: New York Marriott at the Brooklyn Bridge, 333 Adams Street, NY, United States

Start Date: Aug 8End Date: Aug 9, 2026

Overview

Trusted by Thousands of Attendees
Across Our Events

61+

Email if you have questions

Our Speakers

Planning Committee

Binay Shah, MD, MHA

Conference Director

Binayatara

Joshua Sabari, MD

Conference Co-Chair

NYU Langone

Rajwanth Veluswamy, MD

Conference Co-Chair

Abraham Chachoua, MD

Conference Co-Chair

NYU Langone

Amanda Kluxen, RN

Planning Committee

NYU

Oscar Lahoud, MD

Planning Committee

NYU Langone

Corey Langer, MD

Abstract Committee

Vamsi Velcheti, MD

Abstract Committee

Shirish Gadgeel, MBBS

Abstract Committee

Winship Cancer Institute of Emory University

Tina Cascone, MD, PhD

Abstract Committee

MD Anderson

Faculty

Nick Rohs, MD

Session Chair

Mount Sinai

Christine Garcia, MD, MPH

Session Chair

Weill Cornell Medicine

Balazs Halmos, MD

Topic Presenter

Montefiore Einstein Cancer Center

Benjamin Herzberg, MD

Topic Presenter

Columbia University Medical Center

Sarah Goldberg, MD, MPH

Topic Presenter

Yale University

Julia Rotow, MD

Topic Presenter

Dana Farber Cancer Institute

Robert Samstein, MD, PhD

Topic Presenter

Mount Sinai

Grace Dy, MD

Topic Presenter

Roswell Park Cancer Center

Elaine Shum, MD

Topic Presenter

NYU Langone

Douglas Kondziolka, MD

Topic Presenter

NYU Langone

Isabel Preeshagul, DO

Topic Presenter

Memorial Sloan Kettering Cancer Center

Ashish Saxena, MD, PhD

Topic Presenter

Weill Cornell Medicine

Qian Wang, MD

Topic Presenter

Case Western Reserve University

Fionnuala Crowley, MBBS

Topic Presenter

Mount Sinai

Konstantin Dragnev, MD

Topic Presenter

Dartmouth Cancer Center

Sarah Waliany, MD

Topic Presenter

Ankeeta Joshi

Topic Presenter

Vincent Lam, MD

Topic Presenter

Johns Hopkins

Salman Punekar, MD

Topic Presenter

NYU Langone

Saumil Gandhi, MD, PhD

Topic Presenter

MD Anderson

Jamie Chaft, MD

Topic Presenter

Memorial Sloan Kettering Cancer Center

Zoë Swainson, MHA

Topic Presenter

Morana Vojnic, MD, MBA

Topic Presenter

Rutgers Cancer Institute

Brian Henick, MD

Topic Presenter

Christian Diego Rolfo, MD, MBA

Topic Presenter

Hematology and Oncology Department, The Ohio State University, Columbus, OH, USA

Olivia Fankuchen

Topic Presenter

Neel Chudgar, MD

Topic Presenter

Miguel Gonzalez-Velez, MD

Topic Presenter

Alisa Sokoloff, MD

Topic Presenter

Bhavani Potluri, MD

Case Presenter

Joshua Bliss, MD

Case Presenter

Steven Chen, MD PhD

Case Presenter

Margaret Locke, MD

Case Presenter

Northwell Health Cancer Institute

Noah Osei, MD

Case Presenter

Hematology-Oncology, Icahn School of Medicine at Mount Sinai

Renuka Ramchandran, MD

Case Presenter

Rodrigo Paredes, MD

Case Presenter

Hematology-Oncology, Icahn School of Medicine at Mount Sinai

Simran Arjani, MD

Case Presenter

Agenda

Day 1: Saturday, August 8th, 2026

All timings are in Eastern Time (EDT, GMT-04:00) time.

07:00 AM - 08:00 AMRegistration, Breakfast, & Exhibits

08:00 AM - 08:05 AMWelcome

08:05 AM - 09:05 AMSession 1: Targeted Therapy – EGFR (Salon H & I)

Session Chair: Joshua Sabari, MD

08:05 AM - 08:15 AM

EGFR-Mutant NSCLC: Sequencing Therapy After 1L Options – Julia Rotow, MD

08:15 AM - 08:25 AM

Mechanisms of Resistance in EGFR-Mutant Lung Cancer: What Matters Clinically? – Joshua Sabari, MD

08:25 AM - 08:35 AM

Local Therapy in EGFR-Mutant NSCLC: – Saumil Gandhi, MD, PhD

08:35 AM - 08:45 AM

Managing Toxicities of Modern Targeted Therapies: Practical Pearls – Isabel Preeshagul, DO

08:45 AM - 08:55 AM

Case Presentation – Noah Osei, MD

08:55 AM - 09:05 AM

Case- Based Discussion

Moderators:

Joshua Sabari, MD

Panelists:

Julia Rotow, MD; Saumil Gandhi, MD, PhD; Isabel Preeshagul, DO

09:05 AM - 10:05 AMSession 2: Targeted Therapy – Other Mutations (Salon H & I)

Session Chair: Vamsi Velcheti, MD

09:05 AM - 09:15 AM

ALK-Positive NSCLC in 2026: Sequencing Beyond Lorlatinib – Sarah Waliany, MD

09:15 AM - 09:25 AM

ROS1-Positive NSCLC: Resistance and Emerging Therapies – Ashish Saxena, MD, PhD

09:25 AM - 09:35 AM

RET Fusion NSCLC: Current Standards and Future Directions – Rajwanth Veluswamy, MD

09:35 AM - 09:45 AM

HER2-Mutant NSCLC: Where do ADCs fit? – Balazs Halmos, MD

09:45 AM - 09:55 AM

Case Presentation – Rodrigo Paredes, MD

09:55 AM - 10:05 AM

Case Discussion

Moderators:

Vamsi Velcheti, MD

Panelists:

Sarah Waliany, MD; Ashish Saxena, MD, PhD; Rajwanth Veluswamy, MD; Balazs Halmos, MD

10:05 AM - 10:30 AMBreak & Exhibits (Salon F & G) (Non - CME accredited)

10:30 AM - 11:30 AMSession 3: Targeted Therapy – KRAS (Salon H & I)

Session Chair: Rajwanth Veluswamy, MD

10:30 AM - 10:40 AM

Current Standards for KRAS G12C NSCLC: Where Are We Today? – Grace Dy, MD

10:40 AM - 10:50 AM

The Path to Frontline KRAS Inhibition in NSCLC – Shirish Gadgeel, MBBS

10:50 AM - 11:00 AM

Beyond G12C: Emerging Therapeutic Strategies for Non-G12C KRAS Mutations – Benjamin Herzberg, MD

11:00 AM - 11:10 AM

Mechanisms of Resistance and Future Directions in KRAS-Driven NSCLC – Konstantin Dragnev, MD

11:10 AM - 11:20 AM

Case Presentation – Bhavani Potluri, MD

11:20 AM - 11:30 AM

Case Discussion

Moderators:

Rajwanth Veluswamy, MD

Panelists:

Grace Dy, MD; Shirish Gadgeel, MBBS; Benjamin Herzberg, MD; Konstantin Dragnev, MD

11:30 AM - 12:30 PMSession 4: CNS Metastases and High-Risk Disease in NSCLC (Salon H & I)

Session Chair: Nick Rohs, MD

11:30 AM - 11:40 AM

Managing Leptomeningeal Disease – Morana Vojnic, MD, MBA

11:40 AM - 11:50 AM

ctDNA and Minimal Residual Disease in NSCLC: Identifying Patients at Highest Risk of Recurrence – Christian Diego Rolfo, MD, MBA

11:50 AM - 12:00 PM

Immunotherapy for Untreated Brain Metastases: What Have We Learned? – Sarah Goldberg, MD, MPH

12:00 PM - 12:10 PM

Gamma Knife Surgery in 2026: Pushing the Limits of Intracranial Disease Control – Douglas Kondziolka, MD

12:10 PM - 12:20 PM

Case Presentation – Margaret Locke, MD

12:20 PM - 12:30 PM

Case Discussion

Moderators:

Nick Rohs, MD

Panelists:

Morana Vojnic, MD, MBA; Christian Diego Rolfo, MD, MBA; Sarah Goldberg, MD, MPH; Douglas Kondziolka, MD

12:30 PM - 01:00 PMBinaytara's Efforts in Improving Cancer Care Disparities - Dr. Binay Shah (Non - CME accredited)

01:00 PM - 02:00 PMLunch (Salon F & G) & Product Theatre by Regeneron (Golden Boardroom) (Non - CME accredited)

02:00 PM - 03:00 PMSession 5: Early Stage Lung Cancer (Salon H & I)

Session Chair: Abraham Chachoua, MD

02:00 PM - 02:10 PM

Lung Cancer Screening in 2026: Who, When, and How? – Elaine Shum, MD

02:10 PM - 02:20 PM

Perioperative Immunotherapy in Resectable NSCLC: What Is Standard in 2026? – Jamie Chaft, MD

02:20 PM - 02:30 PM

Response-Adapted Therapy and the Future of Curative-Intent Treatment – Tina Cascone, MD, PhD

02:30 PM - 02:40 PM

Surgical vs Radiation Decision-Making in the Modern Era – Neel Chudgar, MD

02:40 PM - 02:50 PM

Case Presentation – Joshua Bliss, MD

02:50 PM - 03:00 PM

Case Discussion

Moderators:

Abraham Chachoua, MD

Panelists:

Elaine Shum, MD; Jamie Chaft, MD; Tina Cascone, MD, PhD; Neel Chudgar, MD

03:00 PM - 04:00 PMImpact Pitch: The Binaytara Research Challenge (Salon H & I) (Non - CME accredited)

04:00 PM - 04:00 PMAdjourn

Acknowledgement of Commercial Support

This activity is supported with an Independent Medical Education grant from Gilead Sciences.

About 2026 Brooklyn Lung Cancer Conference

Overview

Faculty and committee

Our Speakers

Planning Committee

Faculty

Conference program and agenda

Agenda

Venue and map

Accreditations and continuing education

Acknowledgement of Commercial Support

Registration and pricing

Exhibitors and sponsorship

Our Speakers

Planning Committee

Faculty

Agenda

Acknowledgement of Commercial Support